Kingswood Wealth Advisors LLC lifted its position in Aflac Incorporated (NYSE:AFL – Free Report) by 78.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,869 shares of the financial services provider’s stock after purchasing an additional 8,310 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Aflac were worth $2,109,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in Aflac in the 1st quarter valued at $25,000. Groupe la Francaise acquired a new position in shares of Aflac in the 1st quarter valued at $25,000. Archer Investment Corp bought a new position in shares of Aflac during the 2nd quarter worth about $26,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Aflac during the 2nd quarter worth about $27,000. Finally, Evergreen Advisors LLC bought a new position in shares of Aflac during the 1st quarter worth about $29,000. Institutional investors and hedge funds own 67.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Wolfe Research began coverage on shares of Aflac in a research report on Wednesday, August 19th. They set an “underperform” rating and a $103.00 target price on the stock. Evercore increased their price target on shares of Aflac from $109.00 to $115.00 and gave the stock an “underperform” rating in a research report on Monday, July 13th. UBS Group restated a “neutral” rating and set a $125.00 price target (up from $124.00) on shares of Aflac in a research note on Tuesday, October 6th. Barclays reaffirmed an “underweight” rating and set a $101.00 price objective (up from $99.00) on shares of Aflac in a report on Wednesday, October 7th. Finally, Weiss Ratings downgraded Aflac from a “buy (a-)” rating to a “buy (b+)” rating in a report on Tuesday, October 20th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, Aflac presently has an average rating of “Hold” and an average target price of $117.20.
Get Our Latest Stock Analysis on Aflac
Aflac Trading Up 1.0%
Aflac stock opened at $122.16 on Wednesday. The stock has a fifty day moving average price of $116.40 and a two-hundred day moving average price of $115.61. Aflac Incorporated has a 52-week low of $105.43 and a 52-week high of $130.22.
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.76 by ($0.01). The business had revenue of $4.22 billion during the quarter, compared to the consensus estimate of $4.11 billion. During the same period in the previous year, the firm posted $1.78 earnings per share. The business’s revenue for the quarter was down 1.0% on a year-over-year basis. On average, equities research analysts predict that Aflac Incorporated will post 7.04 EPS for the current year.
Aflac Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Investors of record on Wednesday, August 19th were given a dividend of $0.61 per share. The ex-dividend date was Wednesday, August 19th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.0%.
Insider Transactions at Aflac
In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $118.53, for a total value of $13,466,311.83. Following the transaction, the insider directly owned 50,134,329 shares in the company, valued at $5,942,422,016.37. The trade was a 0.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 713,662 shares of company stock worth $83,323,978. Company insiders own 0.80% of the company’s stock.
Aflac Company Profile
Aflac Incorporated (NYSE:AFL) is an insurance company specializing in supplemental health and life insurance. Through its policies, the company helps individuals and families manage expenses that may not be fully covered by major medical insurance, including deductibles, copayments and other out-of-pocket costs.
Aflac offers products such as accident, cancer, critical illness, hospital indemnity, dental and vision, disability, life and long-term care insurance. Many of its supplemental policies provide cash benefits directly to policyholders, who can generally use the funds according to their individual needs.
Read More
- Five stocks we like better than Aflac
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
